人工膵臓デバイスシステムの世界市場レポート 2025年

人工膵臓デバイスシステム市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR13.9％で34億8,000万米ドルに成長します。予測期間の成長は、糖尿病有病率の増加、膵臓がんの有病率の増加、糖尿病と肥満の発生率の増加、低侵襲（MI）ドラッグデリバリーシステムの需要の高まり、糖尿病管理技術の革新の推進に起因すると考えられます。予測期間における主な動向としては、技術革新、研究開発活動の増加、製品承認の増加、提携・協力関係の増加、フォローアップのための遠隔コンサルティング活動の増加などが挙げられます。

膵臓がんの罹患率の増加は、人工膵臓デバイスシステム（APDS）市場の拡大を促進すると予測されます。膵臓がんは、胃の後ろに位置する膵臓に発生する悪性腫瘍です。膵臓がんの開発は、遺伝性膵炎の原因となる遺伝子変異や慢性膵炎の原因となる遺伝子変異など、生活習慣、遺伝的、医学的、環境的要因のミックスに影響されます。人工膵臓デバイスシステムは、主にグルコースを自動的に監視し、適切な量のインスリンを供給することにより、糖尿病患者の血糖値管理を支援するために設計されています。例えば、2024年3月、オーストラリアを拠点とする政府機関であるTheCancer Australiaによると、2023年に新たに膵臓がんと診断された症例は4,506例と推定され、過去5年間の3,751例から増加しています。このように、膵臓がんの有病率の上昇が人工膵臓デバイスシステム市場の成長に寄与しています。

人工膵臓デバイスシステム市場の主なプレーヤーは、血糖値を自動的にモニタリングし、適量のインスリンを投与することで糖尿病管理を改善する自動インスリン送達システムを開発しています。これらのシステムは健康な膵臓の機能を模倣することを目的としており、血糖値の常時モニタリングや手動によるインスリン注射の必要性を軽減します。例えば、2023年5月、米国の医療機器メーカーであるベータ・バイオニクス社は、自動インスリン投与装置であるiLet Insulin-Only Bionic Pancreas SystemのFDA 510（k）認可を取得しました。この人工膵臓システムは、血糖値を調整するために自律的にインスリン投与量を決定し、投与します。このクローズド・ループ・システムは、接続された持続グルコース・モニター（CGM）で測定されたグルコース・レベルに基づいてインスリン投与を調整し、自動調整にはユーザーの体重と食事サイズの推定値のみが必要です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界人工膵臓デバイスシステムPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の人工膵臓デバイスシステム市場：成長率分析
• 世界の人工膵臓デバイスシステム市場の実績：規模と成長, 2019-2024
• 世界の人工膵臓デバイスシステム市場の予測：規模と成長, 2024-2029, 2034F
• 世界人工膵臓デバイスシステム総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の人工膵臓デバイスシステム市場：デバイスタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 閾値サスペンドデバイスシステム
• 制御距離システム
• 制御ターゲットシステム
• 世界の人工膵臓デバイスシステム市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイホルモン
• インスリンのみ
• ハイブリッド
• 世界の人工膵臓デバイスシステム市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 医療センター
• その他のエンドユーザー
• 世界の人工膵臓デバイスシステム市場閾値サスペンドデバイスシステムのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 閾値停止機能付きインスリンポンプ
• 持続血糖モニタリング（CGM）統合システム
• 世界の人工膵臓デバイスシステム市場、制御・距離システムのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハイブリッド閉ループシステム
• 範囲制御機能付きインスリン送達システム
• リアルタイム血糖調整システム
• 世界の人工膵臓デバイスシステム市場制御対象システムのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 完全閉ループ人工膵臓システム
• 標的血糖コントロール機能付きインスリンポンプ
• 自動血糖調節システム

第7章 地域別・国別分析

• 世界の人工膵臓デバイスシステム市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の人工膵臓デバイスシステム市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 人工膵臓デバイスシステム市場：競合情勢
• 人工膵臓デバイスシステム市場：企業プロファイル
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • DexCom Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Tandem Diabetes Care Inc.
• Juvenile Diabetes Research Foundation（JDRF）
• Beta Bionics Inc.
• Glooko Inc.
• Bigfoot Biomedical Inc.
• CeQur SA
• Medtrum Technologies Inc.
• Diabeloop SA
• Beta-O2 Technologies Ltd
• Pancreum Inc.
• TypeZero Technologies LLC
• Inreda Diabetic B.V.
• Defymed SAS
• Admetsys Corporation
• DreaMed Diabetes Ltd

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 人工膵臓デバイスシステム市場2029：新たな機会を提供する国
• 人工膵臓デバイスシステム市場2029：新たな機会を提供するセグメント
• 人工膵臓デバイスシステム市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

An Artificial Pancreas Device System (APDS) is a medical technology designed to automate blood glucose management for people with diabetes. This system combines continuous glucose monitoring (CGM) with an insulin pump and employs a sophisticated algorithm to adjust insulin delivery automatically based on real-time glucose readings. The goal of the device is to replicate the glucose-regulating function of a healthy pancreas, thus minimizing the need for manual blood glucose monitoring and insulin injections, and assisting in keeping blood glucose levels within a target range.

The artificial pancreas device system market features three main types of devices threshold suspend device systems, control-to-range systems, and control-to-target systems. Threshold suspend device systems are insulin pump technologies that automatically halt insulin delivery when blood glucose levels fall below a set threshold. The different treatment types include bi-hormonal, insulin-only, and hybrid systems, with end-users such as hospitals, medical centers, and other healthcare settings.

The artificial pancreas device system market research report is one of a series of new reports from The Business Research Company that provides artificial pancreas device system market statistics, including the artificial pancreas device system industry global market size, regional shares, competitors with artificial pancreas device system market share, detailed artificial pancreas device system market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial pancreas device system industry. These artificial pancreas device system market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial pancreas device system market size has grown rapidly in recent years. It will grow from $1.81 billion in 2024 to $2.07 billion in 2025 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to rising inflow of investment, growing government initiative in clinical research, growing demand for automated systems in glycemic control, intensive R&D efforts by industry players, and increasing geriatric population.

The artificial pancreas device system market size is expected to see rapid growth in the next few years. It will grow to $3.48 billion in 2029 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to growing prevalence of diabetes, increasing prevalence of pancreatic cancer, growing occurrence of diabetes and obesity, rising demand minimally invasive (MI) drug delivery systems, and driving innovation in diabetes management technology. Major trends in the forecast period include technological innovations, increasing research and development activities, increasing product approvals, partnerships and collaborations, and increasing activities in tele consultancy for follow-up.

The growing incidence of pancreatic cancer is projected to drive the expansion of the artificial pancreas device system (APDS) market. Pancreatic cancer is a malignant tumor originating in the pancreas, which is located behind the stomach. The development of pancreatic cancer is influenced by a mix of lifestyle, genetic, medical, and environmental factors, including genetic mutations that can cause hereditary pancreatitis and result in chronic pancreatic inflammation. An artificial pancreas device system is primarily designed to assist individuals with diabetes in managing their blood sugar levels by automatically monitoring glucose and delivering the appropriate amount of insulin. For example, in March 2024, according to theCancer Australia, an Australia-based government agency, estimated that 4,506 new cases of pancreatic cancer were diagnosed in 2023, up from 3,751 cases over the previous five years. Thus, the rising prevalence of pancreatic cancer is contributing to the growth of the artificial pancreas device system market.

Key players in the artificial pancreas device system market are developing automated insulin delivery systems to improve diabetes management by automatically monitoring blood glucose levels and administering the correct amount of insulin. These systems aim to mimic the function of a healthy pancreas, alleviating the need for constant blood sugar monitoring and manual insulin injections. For instance, in May 2023, Beta Bionics, a US-based medical equipment manufacturer, received FDA 510(k) clearance for its iLet Insulin-Only Bionic Pancreas System, an automated insulin delivery device. This artificial pancreas system autonomously determines and delivers insulin doses to regulate blood glucose levels. The closed-loop system adjusts insulin delivery based on glucose levels measured by a connected continuous glucose monitor (CGM), requiring only the user's body weight and a meal size estimate for automatic adjustments.

In September 2023, Abbott Laboratories, a US-based pharmaceutical company, acquired Bigfoot Biomedical for an undisclosed amount. This acquisition strengthens Abbott's position in diabetes care by integrating its leading Freestyle Libre continuous glucose monitoring technology with Bigfoot Biomedical's expertise in automated insulin delivery systems. Bigfoot Biomedical, a US-based company, specializes in developing prototypes of automated insulin delivery systems, also known as artificial pancreas systems.

Major companies operating in the artificial pancreas device system market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Juvenile Diabetes Research Foundation (JDRF), Beta Bionics Inc., Glooko Inc., Bigfoot Biomedical Inc., CeQur SA, Medtrum Technologies Inc., Diabeloop SA, Beta-O2 Technologies Ltd, Pancreum Inc., TypeZero Technologies LLC, Inreda Diabetic B.V., Defymed SAS, Admetsys Corporation, DreaMed Diabetes Ltd

North America was the largest region in the artificial pancreas device system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial pancreas device system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial pancreas device system market includes revenues earned by entities by providing services such as patient monitoring, device maintenance, data management, software updates, healthcare provider consultations, and training and support for patients and healthcare professionals. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial pancreas device system market also includes sales of insulin pumps, continuous glucose monitors, control algorithms and software applications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Pancreas Device System Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial pancreas device system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial pancreas device system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial pancreas device system market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Device Type: Threshold Suspend Device Systems; Control-To-Range Systems; Control-To-Target Systems
• 2) By Treatment Type: Bi-Hormonal; Insulin Only; Hybrid
• 3) By End-User: Hospitals; Medical Centers; Other End-Users
• Subsegments:
• 1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend; Continuous Glucose Monitoring (CGM) Integrated Systems
• 2) By Control-To-Range Systems: Hybrid Closed-Loop Systems; Insulin Delivery Systems with Range Control; Real-Time Glucose Adjustment Systems
• 3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems; Insulin Pumps with Targeted Glucose Control; Automated Glucose Regulation Systems
• Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; DexCom Inc.; Insulet Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Pancreas Device System Market Characteristics

3. Artificial Pancreas Device System Market Trends And Strategies

4. Artificial Pancreas Device System Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Artificial Pancreas Device System Growth Analysis And Strategic Analysis Framework

• 5.1. Global Artificial Pancreas Device System PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Artificial Pancreas Device System Market Growth Rate Analysis
• 5.4. Global Artificial Pancreas Device System Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Artificial Pancreas Device System Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Artificial Pancreas Device System Total Addressable Market (TAM)

6. Artificial Pancreas Device System Market Segmentation

• 6.1. Global Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Threshold Suspend Device Systems
• Control-To-Range Systems
• Control-To-Target Systems
• 6.2. Global Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bi-Hormonal
• Insulin Only
• Hybrid
• 6.3. Global Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Medical Centers
• Other End-Users
• 6.4. Global Artificial Pancreas Device System Market, Sub-Segmentation Of Threshold Suspend Device Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Insulin Pump with Threshold Suspend
• Continuous Glucose Monitoring (CGM) Integrated Systems
• 6.5. Global Artificial Pancreas Device System Market, Sub-Segmentation Of Control-To-Range Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hybrid Closed-Loop Systems
• Insulin Delivery Systems with Range Control
• Real-Time Glucose Adjustment Systems
• 6.6. Global Artificial Pancreas Device System Market, Sub-Segmentation Of Control-To-Target Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fully Closed-Loop Artificial Pancreas Systems
• Insulin Pumps with Targeted Glucose Control
• Automated Glucose Regulation Systems

7. Artificial Pancreas Device System Market Regional And Country Analysis

• 7.1. Global Artificial Pancreas Device System Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Artificial Pancreas Device System Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Pancreas Device System Market

• 8.1. Asia-Pacific Artificial Pancreas Device System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Pancreas Device System Market

• 9.1. China Artificial Pancreas Device System Market Overview
• 9.2. China Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Pancreas Device System Market

• 10.1. India Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Pancreas Device System Market

• 11.1. Japan Artificial Pancreas Device System Market Overview
• 11.2. Japan Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Pancreas Device System Market

• 12.1. Australia Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Pancreas Device System Market

• 13.1. Indonesia Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Pancreas Device System Market

• 14.1. South Korea Artificial Pancreas Device System Market Overview
• 14.2. South Korea Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Pancreas Device System Market

• 15.1. Western Europe Artificial Pancreas Device System Market Overview
• 15.2. Western Europe Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Pancreas Device System Market

• 16.1. UK Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Pancreas Device System Market

• 17.1. Germany Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Pancreas Device System Market

• 18.1. France Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Pancreas Device System Market

• 19.1. Italy Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Pancreas Device System Market

• 20.1. Spain Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Pancreas Device System Market

• 21.1. Eastern Europe Artificial Pancreas Device System Market Overview
• 21.2. Eastern Europe Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Pancreas Device System Market

• 22.1. Russia Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Pancreas Device System Market

• 23.1. North America Artificial Pancreas Device System Market Overview
• 23.2. North America Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Pancreas Device System Market

• 24.1. USA Artificial Pancreas Device System Market Overview
• 24.2. USA Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Pancreas Device System Market

• 25.1. Canada Artificial Pancreas Device System Market Overview
• 25.2. Canada Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Pancreas Device System Market

• 26.1. South America Artificial Pancreas Device System Market Overview
• 26.2. South America Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Pancreas Device System Market

• 27.1. Brazil Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Pancreas Device System Market

• 28.1. Middle East Artificial Pancreas Device System Market Overview
• 28.2. Middle East Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Pancreas Device System Market

• 29.1. Africa Artificial Pancreas Device System Market Overview
• 29.2. Africa Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Pancreas Device System Market Competitive Landscape And Company Profiles

• 30.1. Artificial Pancreas Device System Market Competitive Landscape
• 30.2. Artificial Pancreas Device System Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. DexCom Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Pancreas Device System Market Other Major And Innovative Companies

• 31.1. Tandem Diabetes Care Inc.
• 31.2. Juvenile Diabetes Research Foundation (JDRF)
• 31.3. Beta Bionics Inc.
• 31.4. Glooko Inc.
• 31.5. Bigfoot Biomedical Inc.
• 31.6. CeQur SA
• 31.7. Medtrum Technologies Inc.
• 31.8. Diabeloop SA
• 31.9. Beta-O2 Technologies Ltd
• 31.10. Pancreum Inc.
• 31.11. TypeZero Technologies LLC
• 31.12. Inreda Diabetic B.V.
• 31.13. Defymed SAS
• 31.14. Admetsys Corporation
• 31.15. DreaMed Diabetes Ltd

32. Global Artificial Pancreas Device System Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Pancreas Device System Market

34. Recent Developments In The Artificial Pancreas Device System Market

35. Artificial Pancreas Device System Market High Potential Countries, Segments and Strategies

• 35.1 Artificial Pancreas Device System Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Artificial Pancreas Device System Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Artificial Pancreas Device System Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer